{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:36:32Z","timestamp":1793424992486,"version":"4.5.0"},"reference-count":35,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T00:00:00Z","timestamp":1634774400000},"content-version":"unspecified","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2021,9,25]]},"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:p>Congenital adrenal hyperplasia (CAH), if untreated, carries high morbidity and mortality. A higher incidence of CAH is expected in countries where consanguinity is common, such as in the countries of the WHO Eastern Mediterranean Region (EMRO). CAH is managed through lifelong treatment with fludrocortisone and hydrocortisone. In this analysis, performed in the 22 EMRO countries and territories plus Algeria, we review which countries offer a neonatal screening programme for CAH and describe the barriers and opportunities to access oral fludrocortisone and oral and injectable hydrocortisone. Neonatal CAH screening was only available nationally in Qatar, Kuwait and partially in Lebanon and Saudi Arabia. We reviewed the national lists of essential medicines (NEMLs) and found that 13\/23 (57%) countries included fludrocortisone and 18\/23 (78%) included oral hydrocortisone. Fludrocortisone was not included by any of the low-income countries and oral hydrocortisone was only included by one low-income country. We then contacted paediatric endocrinologists in each country to assess perceived availability of these medicines. Overall, there was a relatively good consistency between inclusion of fludrocortisone and hydrocortisone in the NEML and their actual availability in a country. We propose several mechanisms to improve access, including prequalification by the WHO, a common registration process for groups of countries, pooled procurement, working with local pharmaceutical companies, special access status for medicines not yet registered in a country and compounding. We suggest that access to medicines requires a collaboration between health professionals, families of patients, health authorities, pharmaceutical companies and the WHO.<\/jats:p>","DOI":"10.1136\/bmjgh-2021-007195","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T12:40:15Z","timestamp":1634820015000},"page":"e007195","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Access to fludrocortisone and to hydrocortisone in children with congenital adrenal hyperplasia in the WHO Eastern Mediterranean Region: it takes a village\u2026"],"prefix":"10.1136","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8950-6504","authenticated-orcid":false,"given":"Amanda","family":"Rowlands","sequence":"first","affiliation":[{"name":"Endocrinology and Diabetes Unit, Department of Pediatrics, British Columbia Children's Hospital and University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Global Pediatric Endocrinology and Diabetes, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4090-4672","authenticated-orcid":false,"given":"Asma","family":"Deeb","sequence":"additional","affiliation":[{"name":"Global Pediatric Endocrinology and Diabetes, Vancouver, British Columbia, Canada"},{"name":"Paediatric Endocrinology Division, Sheikh Shakhbout Medical City and Khalifa University, Abu Dhabi, UAE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5962-6209","authenticated-orcid":false,"given":"Asmahane","family":"Ladjouze","sequence":"additional","affiliation":[{"name":"Global Pediatric Endocrinology and Diabetes, Vancouver, British Columbia, Canada"},{"name":"Paediatric endocrinology, Department of Paediatrics, Bab El Oued Teaching hospital, Algiers, Algeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7222-4543","authenticated-orcid":false,"given":"Rasha T","family":"Hamza","sequence":"additional","affiliation":[{"name":"Global Pediatric Endocrinology and Diabetes, Vancouver, British Columbia, Canada"},{"name":"Department of Pediatrics, Pediatric Endocrinology Unit, Faculty of Medicine, Ain Shams University Faculty of Medicine, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0868-0915","authenticated-orcid":false,"given":"Salwa A","family":"Musa","sequence":"additional","affiliation":[{"name":"Global Pediatric Endocrinology and Diabetes, Vancouver, British Columbia, Canada"},{"name":"Pediatric endocrinology, Gaafar Ibn Auf Tertiary Pediatric Hospital and University of Khartoum, Khartoum, Sudan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7038-6533","authenticated-orcid":false,"given":"Jamal","family":"Raza","sequence":"additional","affiliation":[{"name":"Executive Director, National Institute of Child Health, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8281-2114","authenticated-orcid":false,"given":"Farida","family":"Jennane","sequence":"additional","affiliation":[{"name":"Unit\u00e9 d'Endocrinologie\/ Diab\u00e9tologie, Facult\u00e9 de M\u00e9decine de Casablanca, H\u00f4pital Universitaire Abderrahim Harouchi P\u00e9diatrie2 CH Ibn Rochd, Casablanca, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6540-4941","authenticated-orcid":false,"given":"Abdulsalam","family":"Abu-Libdeh","sequence":"additional","affiliation":[{"name":"Global Pediatric Endocrinology and Diabetes, Vancouver, British Columbia, Canada"},{"name":"Pediatric Endocrinology Unit, Department of Pediatrics, Al-Quds Medical School Makassed Islamic Hospital, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5167-2064","authenticated-orcid":false,"given":"Jean-Pierre","family":"Chanoine","sequence":"additional","affiliation":[{"name":"Endocrinology and Diabetes Unit, Department of Pediatrics, British Columbia Children's Hospital and University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Global Pediatric Endocrinology and Diabetes, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,10,21]]},"reference":[{"key":"2025073014263586000_6.10.e007195.1","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jpag.2017.04.001","article-title":"Congenital adrenal hyperplasia","volume":"30","author":"Witchel","year":"2017","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"2025073014263586000_6.10.e007195.2","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2015.03.002"},{"key":"2025073014263586000_6.10.e007195.3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jpeds.2019.12.057","article-title":"Clinical impact and cost efficacy of newborn screening for congenital adrenal hyperplasia","volume":"220","author":"Fox","year":"2020","journal-title":"J Pediatr"},{"key":"2025073014263586000_6.10.e007195.4","unstructured":"World Health Organization . WHO list of essential medicines for children. 7th edn, 2019. Available: https:\/\/www.who.int\/publications\/i\/item\/WHOMVPEMPIAU201907 [Accessed Aug 2021]."},{"key":"2025073014263586000_6.10.e007195.5","unstructured":"World Health Organization . WHO model list of essential medicines. 21st edn, 2019. Available: https:\/\/www.who.int\/publications\/i\/item\/WHOMVPEMPIAU2019.06 [Accessed Aug 2021]."},{"key":"2025073014263586000_6.10.e007195.6","unstructured":"Global pediatric endocrinology and diabetes (GPED). Available: www.globalpedendo.org [Accessed Aug 2021]."},{"key":"2025073014263586000_6.10.e007195.7","unstructured":"EMRO . Eastern Mediaterranean regional office. Available: www.who.int\/about\/regions\/en\/ [Accessed Aug 2021]."},{"key":"2025073014263586000_6.10.e007195.8","doi-asserted-by":"crossref","first-page":"e683","DOI":"10.1210\/clinem\/dgaa016","article-title":"Cognitive function of children and adolescents with congenital adrenal hyperplasia: importance of early diagnosis","volume":"105","author":"Messina","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2025073014263586000_6.10.e007195.9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1515\/jpem-2019-0345","article-title":"Assessment of health-related quality of life in Egyptian children and adolescents with congenital adrenal hyperplasia","volume":"33","author":"Musa","year":"2020","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2025073014263586000_6.10.e007195.10","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a five-year retrospective study in the children's Hospital of Damascus, Syria","volume":"2015","author":"Sheikh Alshabab","year":"2015","journal-title":"Qatar Med J"},{"key":"2025073014263586000_6.10.e007195.11","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1073\/pnas.0906079106","article-title":"Evolution in health and medicine Sackler Colloquium: consanguinity, human evolution, and complex diseases","volume":"107 Suppl 1","author":"Bittles","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025073014263586000_6.10.e007195.12","first-page":"159","article-title":"Consanguineous marriages and endocrine diseases in Arab societies","volume":"15","author":"Ahmad","year":"2017","journal-title":"Pediatr Endocrinol Rev"},{"key":"2025073014263586000_6.10.e007195.13","first-page":"90","article-title":"Diagnosis and outcome in Maghreb patients with 21-hydroxylase deficient congenital adrenal hyperplasia: urgent need for newborn screening","volume":"154","author":"Ladjouze","year":"2018","journal-title":"Horm Res Paediatr"},{"key":"2025073014263586000_6.10.e007195.14","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/jpc.13469","article-title":"Expanded newborn screening program in Saudi Arabia: incidence of screened disorders","volume":"53","author":"Alfadhel","year":"2017","journal-title":"J Paediatr Child Health"},{"key":"2025073014263586000_6.10.e007195.15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.26719\/2014.20.1.17","article-title":"Expanding the comprehensive national neonatal screening programme in the United Arab Emirates from 1995 to 2011","volume":"20","author":"Al Hosani","year":"2014","journal-title":"East Mediterr Health J"},{"key":"2025073014263586000_6.10.e007195.16","doi-asserted-by":"crossref","DOI":"10.1186\/s12887-015-0529-y","article-title":"Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study","volume":"15","author":"Tsuji","year":"2015","journal-title":"BMC Pediatr"},{"key":"2025073014263586000_6.10.e007195.17","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2011-300234"},{"key":"2025073014263586000_6.10.e007195.18","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.624507","article-title":"Analysis of the screening results for congenital adrenal hyperplasia involving 7.85 million newborns in China: a systematic review and meta-analysis","volume":"12","author":"Li","year":"2021","journal-title":"Front Endocrinol"},{"key":"2025073014263586000_6.10.e007195.19","first-page":"1","article-title":"Dexamethasone therapy of congenital adrenal hyperplasia and the myth of the \"growth toxic\" glucocorticoid","volume":"2010","author":"Rivkees","year":"2010","journal-title":"Int J Pediatr Endocrinol"},{"key":"2025073014263586000_6.10.e007195.20","doi-asserted-by":"publisher","DOI":"10.1186\/1687-9856-2009-274682"},{"key":"2025073014263586000_6.10.e007195.21","unstructured":"WHO . WHO model Lists of essential medicines: WHO global EML, 2021. Available: https:\/\/www.who.int\/groups\/expert-committee-on-selection-and-use-of-essential-medicines\/essential-medicines-lists [Accessed Aug 2021]."},{"key":"2025073014263586000_6.10.e007195.22","unstructured":"The World Bank . Gross national income (GNI) per capita, Atlas method (current USD), 2021. Available: https:\/\/data.worldbank.org\/indicator\/NY.GNP.PCAP.CD [Accessed Aug 2021]."},{"key":"2025073014263586000_6.10.e007195.23","unstructured":"World Health Organization . Essential medicines and health products information portal, 2021. Available: https:\/\/digicollections.net\/medicinedocs\/#cl\/9 [Accessed Aug 2021]."},{"key":"2025073014263586000_6.10.e007195.24","unstructured":"DK News . Industrie pharmaceutique les modalit\u00e9s de d\u00e9livrance de l'autorisation d'utilisation de m\u00e9dicaments non enregistr\u00e9s fix\u00e9es, 2021. Available: http:\/\/www.dknews-dz.com\/article\/131848-industrie-pharmaceutique-les-modalites-de-delivrance-de-lautorisation-dutilisation-de-medicaments-non-enregistres-fixees.html [Accessed Aug 2021]."},{"key":"2025073014263586000_6.10.e007195.25","unstructured":"WHO . World Health organization prequalification program, 2021. Available: https:\/\/www.who.int\/rhem\/prequalification\/prequalification_of_medicines\/en\/ [Accessed Aug 2021]."},{"key":"2025073014263586000_6.10.e007195.26","unstructured":"Azatyan S . Collaborative Registration Procedure - overview of main principles. World Health Organization Virtual Joint Meeting. 30 November - 3 December 2020, 2021. Available: https:\/\/extranet.who.int\/pqweb\/sites\/default\/files\/documents\/CRP_Overview.pdf [Accessed Aug 2021]."},{"key":"2025073014263586000_6.10.e007195.27","unstructured":"World Health Organization . Accelerated registration of Prequalified finished pharmaceutical products, 2021. Available: https:\/\/extranet.who.int\/pqweb\/medicines\/collaborative-registration-faster-registration [Accessed Aug 2021]."},{"key":"2025073014263586000_6.10.e007195.28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003133","article-title":"Coming together to improve access to medicines: the genesis of the East African community's medicines regulatory harmonization initiative","volume":"17","author":"Sillo","year":"2020","journal-title":"PLoS Med"},{"key":"2025073014263586000_6.10.e007195.29","unstructured":"Algeria, Morocco and Tunisia changing their regulatory landscape? 2018. Available: https:\/\/clarivate.com\/blog\/algeria-morocco-tunisia-changing-regulatory-landscape\/ [Accessed Aug 2021]."},{"key":"2025073014263586000_6.10.e007195.30","unstructured":"Nemzoff C , Chalkidou K , Over M . Aggregating demand for pharmaceuticals is appealing, but pooling is not a panacea Centre for Global Development; 2019. https:\/\/www.cgdev.org\/publication\/aggregating-demand-pharmaceuticals-appealing-pooling-not-panacea [Accessed Aug 2021]."},{"key":"2025073014263586000_6.10.e007195.31","unstructured":"PAHO strategic fund, 2021. Available: https:\/\/www.paho.org\/en\/paho-strategic-fund [Accessed Aug 2021]."},{"key":"2025073014263586000_6.10.e007195.32","unstructured":"Sick Kids Hospital . Compounding pharmacy service, 2021. Available: https:\/\/www.sickkids.ca\/en\/care-services\/for-health-care-providers\/compounding-service\/ [Accessed Aug 2021]."},{"key":"2025073014263586000_6.10.e007195.33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0939-6411(02)00159-5","article-title":"Stability of fludrocortisone acetate solutions prepared from tablets and powder","volume":"55","author":"Cisternino","year":"2003","journal-title":"Eur J Pharm Biopharm"},{"key":"2025073014263586000_6.10.e007195.34","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/ijns6040076","article-title":"We all have a role to play: Redressing inequities for children living with CAH and other chronic health conditions of childhood in resource-poor settings","volume":"6","author":"Armstrong","year":"2020","journal-title":"Int J Neonatal Screen"},{"key":"2025073014263586000_6.10.e007195.35","unstructured":"Alayadhi N . Establishing an essential medicine list for the state of Kuwait. doctoral thesis University of Bradford; 2017. http:\/\/hdl.handle.net\/10454\/15742 [Accessed Aug 2021]."}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2021-007195","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T21:26:47Z","timestamp":1753910807000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2021-007195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":35,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10,21]]},"published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10.1136\/bmjgh-2021-007195"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2021-007195","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}